GSK Buys Remaining 30% Shares In Indonesia Unit For $40 Million
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline said it has paid $40 million to take 100% control of its Indonesia consumer health-care unit as it continued to shift its operations around to better position it to become stronger in emerging markets.